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Abstract
The mechanism of Na-dependent transport of L-carnitine via the carnitine/organic cation transporter OCTN2 and the
subcellular localization of OCTN2 in kidney were studied. Using plasma membrane vesicles prepared from HEK293 cells
that were stably transfected with human OCTN2, transport of L-carnitine via human OCTN2 was characterized. Uptake of
L-[3H]carnitine by the OCTN2-expressing membrane vesicles was significantly increased in the presence of an inwardly
directed Na gradient, with an overshoot, while such transient uphill transport was not observed in membrane vesicles from
cells that were mock transfected with expression vector pcDNA3 alone. The uptake of L-[3H]carnitine was specifically
dependent on Na and the osmolarity effect showed that Na significantly influenced the transport rather than the binding.
Changes of inorganic anions in the extravesicular medium and of membrane potential by valinomycin altered the initial
uptake activity of L-carnitine by OCTN2. In addition, the fluxes of L-carnitine and Na were coupled with 1:1 stoichiometry.
Accordingly, it was clarified that Na is coupled with flux of L-carnitine and the flux is an electrogenic process. Furthermore,
OCTN2 was localized on the apical membrane of renal tubular epithelial cells. These results clarified that OCTN2 is
important for the concentrative reabsorption of L-carnitine after glomerular filtration in the kidney. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
L-Carnitine (3-hydroxy-4-(trimethylammonio)buta-
noate) is a water-soluble vitamin and has a physio-
logically important role in the L-oxidation of long-
chain fatty acids by facilitating transport of fatty
acids across the inner membrane of mitochondria
as acylcarnitines. L-Carnitine is supplied both from
the diet and by biosynthesis in certain tissues such as
liver, so it has to be delivered from plasma to the
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intracellular space of the tissues where L-oxidation
proceeds. Furthermore, although L-carnitine is elim-
inated from the kidney by glomerular ¢ltration, it is
retained in the body by reabsorption in the renal
epithelial cells. Accordingly, L-carnitine must be
transported across cellular membranes in kidney
and other tissues. There have been many studies on
L-carnitine transport using animals and human tissue
samples, and Na-dependent and -independent sys-
tems have been identi¢ed [1^5]. They are also classi-
¢ed as high-a⁄nity and low-a⁄nity transport mech-
anisms, and both types may function in parallel. The
Na-dependent high-a⁄nity transporter seems to be
important for the concentrative uptake of L-carnitine
into tissues from plasma, in which the physiological
concentration is about 50 WM. Systemic carnitine
de¢ciency (SCD), which causes severe symptoms in
childhood, such as cardiomyopathy, skeletal myopa-
thy and hyperglycemia, is caused by an inherited
functional defect of Na-dependent high-a⁄nity car-
nitine transporter(s) in kidney and muscle, thereby
decreasing reabsorption in kidney and distribution
to muscle in humans [6^8].
In Na-dependent transport of L-carnitine, two
mechanisms have been reported on the basis of var-
ious experimental methods, including Na-dependent
binding and Na-dependent transport. In human
placental brush-border membrane vesicles, apparent
uptake of L-carnitine was signi¢cantly high in the
presence of Na, although the apparent uptake did
not show uphill transport, namely overshoot uptake,
which is typically observed in the Na-coupled trans-
port of substrates such as D-glucose [9]. In renal
brush-border membrane vesicles, overshoot uptake
was observed in the presence of an inwardly directed
Na gradient [9^11], suggesting the presence of Na-
coupled transport of L-carnitine. However, one of
those studies showed Na-dependent but electroneu-
tral transport of L-carnitine [10], while the other
study demonstrated an enhancement of L-carnitine
transport by inside-negative membrane potential
[11]. So, at present the mechanism of the Na depen-
dence observed in L-carnitine transport is not well
established.
As one of the Na-dependent high-a⁄nity trans-
porters of L-carnitine, we isolated human and mouse
OCTN2, which are members of the carnitine/organic
cation transporter OCTN family [12^14]. The ¢rst
member of the OCTN family, OCTN1, showed
structural similarity to members of the previously
known organic cation transporter OCT family and
exhibited sodium-independent organic cation trans-
port activity [12,15,16]. OCTN2, isolated as a homo-
logue of OCTN1, showed organic cation transport
activity, as well as carnitine transport activity [17^
19]. The Km values of human OCTN2 for L-carnitine
and the organic cation, tetraethylammonium (TEA),
were 4.3 WM and 304 WM, respectively ([13] and un-
published observation). In addition, human OCTN2
showed predominant Na dependence in L-carnitine
transport. Therefore, OCTN2 is the ¢rst Na-depen-
dent high-a⁄nity transporter of L-carnitine. The
physiological importance of OCTN2 was ¢rst identi-
¢ed by the analysis of mutations in the OCTN2 gene
of SCD patients and their families, as well as in a
SCD model animal, juvenile visceral steatosis (jvs)
mouse [20]. At present, various mutations of the
OCTN2 gene in SCD patients are known and
OCTN2 has been con¢rmed as the causative gene
for SCD [21^25]. Since OCTN2 is expressed in
many tissues, including kidney, placenta, skeletal
muscle and heart, it is assumed that OCTN2 may
be functional in these tissues, and previous ¢ndings
of L-carnitine transport in these tissues may be as-
cribed at least in part to OCTN2. Thus, it is essential
to clarify the mechanism of the Na dependence of
L-carnitine transport via OCTN2, because the role of
Na in L-carnitine transport is still controversial and
the result may allow us to identify the responsible
carnitine transporter molecule in each tissue.
The purpose of the present study is to clarify the
role of Na in OCTN2-mediated L-carnitine trans-
port. Sodium dependence has several mechanisms,
such as e¡ect on speci¢c binding, speci¢c coupling
with substrate transport, and other allosteric e¡ects.
In the transport of nutrients such as D-glucose and
amino acids, a sodium ion gradient supplies energy
for uphill transport of substrates, and in such a case
OCTN2 can accumulate L-carnitine against a concen-
tration gradient. We therefore examined the possibil-
ity of Na-coupled transport of L-carnitine via hu-
man OCTN2 using membrane vesicles prepared from
cultured cells transfected with human OCTN2
cDNA, since membrane vesicles are suitable for stud-
ies to identify the driving force of a transporter by
manipulating intra- and extravesicular constituents.
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2. Materials and methods
2.1. Reagents
L-[methyl-3H]Carnitine hydrochloride (65 Ci/
mmol) was purchased from Moravec Biochemicals
(Brea, CA, USA). Other reagents, including those
for cell culture, membrane preparation and transport
experiments, were obtained from Sigma Chemicals
(St. Louis, MO, USA), Wako Pure Chemical Indus-
tries (Osaka, Japan), and Life Technologies (Rock-
ville, MD, USA). HEK293 cells were obtained from
Health Science Research Resources Bank (Tokyo,
Japan).
2.2. Cell culture and preparation of plasma membrane
vesicles
HEK293 cells were routinely grown in Dulbecco’s
modi¢ed Eagle’s medium containing 10% fetal calf
serum (Life Technologies), penicillin, and streptomy-
cin in a humidi¢ed incubator at 37‡C and 5% CO2.
HEK293 cells were transfected with human OCTN2
subcloned into the BamHI site of pcDNA3, an ex-
pression vector DNA (Invitrogen, San Diego, CA,
USA), or pcDNA3 vector alone using LipofectAM-
INE as follows. Ten micrograms of pcDNA3 with or
without human OCTN2 cDNA insert and 30 Wl of
Lipofectamine reagent (Life Technologies) were incu-
bated at room temperature for 45 min in serum-free
culture medium and were added to HEK293 cells
that had been cultured and rinsed with Ca2- and
Mg2-free phosphate-bu¡ered saline (pH 7.4). The
next day the cells were plated at a density of
2U105 cells/dish (100 mm). The cells were cultured
in the presence of 1 mg/ml G418 (Life Technologies)
and a single colony was isolated at day 14. The ex-
pression of human OCTN2 was screened by measur-
ing the uptake of L-[3H]carnitine and reverse tran-
scription (RT)-PCR analysis as described below.
The method used for membrane vesicle prepara-
tion is essentially as described previously [26]. The
obtained cell clone that expresses human OCTN2
was cultured on 30 plastic dishes (150 mm in diam-
eter) containing 1 mg/ml G418 and when they
reached con£uence the cells were harvested by scrap-
ing with rubber policemen and washed twice by cen-
trifugation in phosphate-bu¡ered saline (PBS). The
cells were suspended in 25 ml of bu¡er 1 (10 mM
NaCl, 1.5 mM MgCl2, 0.02 mM phenylmethylsul-
fonyl £uoride, 10 mM Tris^HCl, pH 7.4) and placed
on ice for 30 min. The cells were incubated in a cell
disruption bomb (Parr 4635) and equilibrated at
700 psi by nitrogen gas with gentle stirring for 20
min. Then the pressure was released, ethylenediami-
netetraacetic acid was added to a ¢nal concentration
of 1 mM and the content was homogenized with a
Te£on-glass homogenizer (20 strokes) at 4‡C. The
cell homogenate was collected and centrifuged for
5 min at 1000 rpm and 4‡C. The supernatant was
layered on bu¡er 2 (10 mM Tris^HCl, pH 7.4 and
35% sucrose) in a centrifuge tube and centrifuged for
90 min at 18 000Ug and 4‡C. The white-colored £uf-
fy layer at the boundary of bu¡er 2 was collected,
suspended in bu¡er 3 (150 mM mannitol, 75 mM
potassium gluconate and 10 mM HEPES^Tris, pH
7.4) and centrifuged at 100 000Ug for 2 h at 4‡C.
The resultant pellet was again suspended in bu¡er
3 and centrifuged at 100 000Ug for 3 h at 4‡C. The
¢nal pellet was suspended in bu¡er 3 and stored at
380‡C until used for transport experiments. The
content of protein in each preparation was measured
by the method reported by Bradford, using a Bio-
Rad protein assay kit [27].
2.3. Transport measurement by membrane vesicles
Transport studies were performed by a rapid ¢ltra-
tion technique at 25‡C. Membrane vesicles stored at
380‡C were thawed rapidly at 37‡C and kept on ice.
After 30 min preincubation at 25‡C, 10 Wl of mem-
brane vesicle suspension containing 20 Wg protein
was mixed with 90 Wl of drug solution containing
radiolabeled L-carnitine in bu¡er 4 (usually 150
mM NaCl, 20 mM mannitol, 10 mM HEPES^Tris,
pH 7.4) to initiate uptake studies. The uptake reac-
tion was terminated by diluting with 1 ml of bu¡er 5
(20 mM mannitol, 160 mM potassium chloride,
5 mM HEPES^Tris, pH 7.4) at 4‡C. The diluted
sample was ¢ltered immediately using a membrane
¢lter (Millipore, HAWP, 0.45 Wm pore size) and
washed four times with bu¡er 5. The radioactivity
retained on the membrane ¢lter was quantitated
with a liquid scintillation counter.
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2.4. RT-PCR analysis
Total RNA from HEK293 cells was isolated by
using Rneasy MINI kit (Qiagen). After treatment
of total RNA with DNase I, ¢rst strand cDNA
was prepared from 4.8 Wg of RNA and ampli¢ed
using OCTN2-speci¢c primer pairs (5P-CATCTT-
TGTGAACTGCTTCCTTTC-3P and 5P-TGACTCC-
AAACTTGCCCACCATCA-3P). These primers cor-
respond to nucleotide positions 1236^1259 (sense)
and 1418^1441 (antisense) of OCTN2 cDNA. PCR
was performed for 30 cycles of 94‡C for 30 s, 55‡C
for 30 s, and 72‡C for 30 s.
2.5. Data analysis
Initial uptake rates were obtained by measuring
the uptake at 1 min. To estimate kinetic parameters
for saturable transport of L-carnitine and the stoichi-
ometry between Na and L-carnitine, the uptake
rates were ¢tted to the following equations by means
of nonlinear least-squares regression analysis using
WinNonlin (Scienti¢c Consulting, Cary, NC).
v  VmaxUs=Km  s 1
v0  VmaxUNan=fKnm  Nang 2
where v and vP and s are the uptake rates and con-
centration of substrate (L-carnitine or sodium ions),
respectively, and Km, Vmax and n are the half-satu-
ration concentration (Michaelis constant), the maxi-
mum transport rate and the Hill coe⁄cient, respec-
tively. All data were expressed as mean þ S.E.M. and
statistical analysis was performed by use of Student’s
t-test. The criterion of signi¢cance was taken to be
P6 0.05. Each transport study was repeated at least
three times and they gave essentially the same results,
so typical results are shown here.
2.6. Immunohistochemical study of OCTN2 in kidney
Rabbit anti-OCTN2 polyclonal antibody was
raised against a synthetic peptide corresponding to
the COOH-terminal 19 amino acid residues of mouse
OCTN2 (TRMQKDGEESPTVLKSTAF), as de-
scribed previously [14]. The COOH-terminal of rat
homologue (TRTQKDGGESPTVLKSTAF) di¡ers
from the mouse sequence in two amino acid residues,
T of the third and G of the eighth position, as shown
in italic [28,29]. Immunohistochemical analysis was
performed as described elsewhere [30] with minor
modi¢cations. In brief, after ¢xation of the mice
and rats by perfusion with 4% paraformaldehyde,
the kidneys were removed by dissection and further
¢xed by immersion in the same ¢xative. They were
then frozen and cut into 10 Wm sections by means of
a cryostat. The sections were ¢rst incubated with
anti-OCTN2 polyclonal antibody at 1/10 dilution
or normal rabbit IgG (Dako) for 2 h at room tem-
perature. The site of immunoreaction was revealed
by successive treatment of the sections with biotinyl-
ated anti-rabbit IgG antibody, Avidin DH, biotinyl-
ated horseradish peroxidase (Vector Laboratories,
Burlingame, CA, USA), and 3P,3P-diaminobenzidine
tetrahydrochloride (Wako Pure Chemical Industries)
in the presence of 0.006% hydrogen peroxide. The
specimens were examined with an Axiovert S 100
microscope (Carl Zeiss) and the images were cap-
tured with an MC 80 DX camera.
3. Results
3.1. Establishment of HEK293 cells stably transfected
with human OCTN2
Among HEK293 cell lines transfected with human
OCTN2, one clone was selected as a stably OCTN2-
expressing cell line. Fig. 1a shows the uptake activity
of L-[3H]carnitine by the cell line, compared with
the uptake by cells transfected with the expression
vector pcDNA3 alone (mock). The uptake of
L-[3H]carnitine by the OCTN2-transfected cell line
¢nally selected was 26.8 þ 0.87 pmol/mg protein/
3 min at the concentration of 10 nM, which is about
173 times higher than that by the cell line transfected
with expression vector pcDNA3 alone (mock,
0.155 þ 0.004 pmol/mg protein/3 min). To con¢rm
that the activity can be ascribed to OCTN2 gene
transfection, expression of messenger RNA of
OCTN2 was studied by RT-PCR. In human
OCTN2-transfected cells the corresponding band to
OCTN2 gene was observed and the band was not
detectable in mock cells, while it cannot be excluded
that OCTN2 is expressed in native HEK293 cells to
some extent. From these results, the cell line was
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con¢rmed to be adequate to use for the character-
ization of OCTN2 function by correcting the uptake
by mock cells from the apparent uptake by the
OCTN2-expressing cells.
3.2. Time course and Na+ dependence of L-carnitine
uptake
Uptake of L-[3H]carnitine by OCTN2 was mea-
sured using membrane vesicles prepared from
HEK293 cells transfected with OCTN2 cDNA or
cells expressing pcDNA3 vector alone (mock cells).
Fig. 2a shows the time courses of the uptake of
L-[3H]carnitine in the presence and absence of extra-
vesicular Na. Here, in the absence of Na, the ions
were replaced with N-methylglucamine. Overshoot
uptake of L-[3H]carnitine was observed only in the
presence of Na by membrane vesicles from the
OCTN2-expressing cells. No overshoot uptake in
the presence of Na was observed in the case of
membrane vesicles from mock cells. Although
steady-state uptake by OCTN2-bearing membrane
Fig. 1. Establishment of stably OCTN2-expressing HEK293 cells. a shows the uptake of L-[3H]carnitine (10 nM) by HEK293 cells
transfected with human OCTN2 (closed bar) or with vector pcDNA3 alone (open bar). b shows the expression of human OCTN2
mRNA detected by RT-PCR. The reaction was performed as described in Section 2 and the RT-PCR products were analyzed by aga-
rose gel electrophoresis followed by staining with ethidium bromide. The speci¢c product from human OCTN2 was 205 bp in size.
Fig. 2. Time course of L-carnitine uptake by membrane vesicles expressing OCTN2 (a) and osmolarity e¡ect (b). Membrane vesicles
from OCTN2-expressing (circles) and mock HEK293 cells (triangles) were suspended in bu¡er 3 containing 75 mM potassium gluco-
nate, 150 mM mannitol, 10 mM HEPES^Tris, pH 7.4. Uptake of L-[3H]carnitine (40 nM) was measured in the bu¡er containing
20 mM mannitol and 150 mM sodium chloride (closed symbols) or N-methylglucamine chloride (open symbols) at pH 7.4 bu¡ered by
10 mM HEPES^Tris. In the study of the osmolarity e¡ect on L-[3H]carnitine uptake, uptake was terminated using isotonic (160 mM
potassium chloride, 20 mM mannitol and 5 mM HEPES^Tris, pH 7.4, open bar) or hypotonic (5 mM HEPES^Tris, pH 7.4, dotted
bar) stop solution. The osmolarity of stop solutions was about 320 mosm/kg or 5 mosm/kg, respectively. The results are shown as
means and S.E.M. of four determinations. When the S.E.M. is smaller than the symbols, it is not shown.
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vesicles showed higher uptake in the presence of
Na, the di¡erence was very small compared with
the di¡erence at the initial stage. These observations
demonstrated that OCTN2 mediates the Na-
coupled transport of L-carnitine. Fig. 2b shows the
osmolarity e¡ect on the initial uptake of L-carnitine
by the membrane vesicles. When membrane vesicles
were collapsed by washing with low osmolarity me-
dium, the apparent initial uptake was signi¢cantly
decreased in the case of OCTN2-expressing mem-
brane vesicles, while the osmolarity e¡ect was mini-
mum in membrane vesicles from mock cells. So, the
observed overshoot transport of L-[3H]carnitine by
OCTN2-expressing cells shown in Fig. 2a was largely
accounted for by intravesicular accumulation rather
than the binding to the membranes, although there is
some contribution of Na-dependent binding of L-
carnitine to the membrane vesicles as reported in
other studies [9].
3.3. Cation and anion dependence of
OCTN2-mediated uptake
To study the speci¢city of L-carnitine uptake by
OCTN2 to Na, the e¡ect of replacement of Na
in the extravesicular medium with various cations
was examined. Fig. 3 shows the initial uptake of L-
[3H]carnitine by OCTN2-expressing and mock mem-
brane vesicles. The results are shown as OCTN2-spe-
ci¢c uptake after correction for the uptake by mock
membrane vesicles. L-[3H]Carnitine uptake was high-
est in the presence of Na, and lithium ions partially
supported the uptake activity, while other cations
such as potassium, rubidium, cesium or choline af-
forded negligible uptake. Here, choline showed the
lowest uptake; this may be explained by competitive
inhibition of L-carnitine uptake, because a high con-
centration of choline reduces the uptake of L-carni-
tine via OCTN2. The e¡ect of inorganic anions was
also studied by replacing chloride ions with thiocya-
nate, nitrate, gluconate or sulfate ions. Compared
with chloride ions, thiocyanate and nitrate ions af-
forded higher uptake and gluconate and sulfate ions
a¡orded lower uptake, although the e¡ects were
small.
3.4. Concentration dependence on L-carnitine uptake
and stoichiometry with Na+
The concentration dependence of Na-dependent
L-carnitine uptake by OCTN2-expressing membrane
vesicles was studied. The initial uptake rate was de-
Fig. 3. E¡ect of inorganic cations and anions on OCTN2-mediated uptake of L-[3H]carnitine by membrane vesicles. Uptake of
L-[3H]carnitine (40 nM) by OCTN2-expressing and mock vesicles was measured for 1 min. When sodium or chloride ions were re-
placed with other cations or anions, chloride or sodium ions were used as counterions, respectively. The results are shown as OCTN2-
speci¢c uptake, obtained by subtracting the uptakes by mock membrane vesicles from those by OCTN2-expressing vesicles, and ex-
pressed as a percentage of the uptake in the presence of sodium chloride. Each value represents the mean and S.E.M. of three deter-
minations. *Signi¢cantly di¡erent from control (sodium chloride bu¡er).
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termined at 1 min. After subtraction of the uptake by
mock vesicles, the uptake of L-carnitine was satura-
ble (Fig. 4a) and nonlinear least-squares analysis
showed half-saturation concentration and Vmax val-
ues of 2.66 þ 0.75 WM and 7.13 þ 0.71 pmol/min/mg
protein, respectively. Uptake of a tracer concentra-
tion (40 nM) of L-carnitine exhibited a nonlinear
relationship with extravesicular Na concentration
with apparent half-saturation Na concentration of
2.34 þ 0.22 mM as shown in Fig. 4b. Hill plot anal-
ysis showed that the stoichiometry of transport of L-
carnitine and Na was 0.88, suggesting that one Na
molecule is associated with the transport of one mol-
ecule of L-carnitine. Thus, it appears that transport
of L-carnitine is an electrogenic process.
3.5. E¡ect of membrane potential on
OCTN2-mediated L-carnitine uptake
The electrogenicity of Na-coupled L-carnitine
transport via OCTN2 was studied by examining the
e¡ect of valinomycin-induced potassium di¡usion
Fig. 4. L-Carnitine (a) and sodium ion (b) concentration de-
pendences of OCTN2-mediated uptake of L-carnitine. (a) Initial
uptake of L-carnitine by membrane vesicles at various concen-
trations of L-carnitine from 40 nM to 50 WM was measured for
1 min. The uptakes by OCTN2 were obtained by subtracting
those of membrane vesicles prepared from mock cells from
the total. The solid line represents the uptake estimated from
the kinetic parameters, Km and Vmax, shown in Section 3.
(b) L-[3H]Carnitine uptake (40 nM) by membrane vesicles was
measured at various concentration of sodium ion from 0 to
150 mM for 1 min. OCTN2-mediated uptake was obtained as
the uptakes by OCTN2-expressing vesicles minus those by
mock vesicles and is shown by Hill plots. Sodium ions were re-
placed with N-methylglucamine to maintain the osmolarity. The
results are shown as means and S.E.M. of four determinations.
When the S.E.M. is smaller than the symbols, it is not shown.
Fig. 5. E¡ect of valinomycin on OCTN2-mediated L-carnitine
uptake by membrane vesicles. Uptake of L-[3H]carnitine
(40 nM) was measured in 10 mM HEPES^Tris bu¡er, pH 7.4,
containing 150 mM NaCl, 20 mM mannitol and 45 WM valino-
mycin (closed symbols) or 0.25% ethanol alone (open symbols),
which was used to dissolve valinomycin. Uptakes by OCTN2-
expressing and mock vesicles are shown by circles and triangles,
respectively. The results are shown as means and S.E.M. of
four determinations. When the S.E.M. is smaller than the sym-
bols, it is not shown.
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potential on L-carnitine uptake by the membrane
vesicles in the presence of an outwardly directed
potassium gradient, as shown in Fig. 5. When
membrane potential was maintained relatively nega-
tive by using valinomycin, the initial uptake of
L-[3H]carnitine was transiently increased compared
with that in the absence of valinomycin. In mock
membrane vesicles no e¡ect of valinomycin was ob-
Fig. 6. Immunolocalization of OCTN2 protein in kidney of mice (a,b) and rats (c). Cryosections (10 Wm) of mouse and rat kidneys
were incubated with the a⁄nity-puri¢ed antiserum (10-fold dilution) against mouse OCTN2 (a,c) or normal anti-rabbit IgG (25 Wg
IgG/ml) and examined under an Axiovert S 100 microscope. The apical membrane side of renal tubules was speci¢cally stained by
antibody against mouse OCTN2, in both mice and rats.
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served. Furthermore, the steady-state uptakes by
membrane vesicles from OCTN2-expressing cells in
the absence and presence of valinomycin were com-
parable. These results demonstrated that the e¡ect of
valinomycin cannot be ascribed to nonspeci¢c dam-
age to the membrane vesicles, and the alteration of
L-[3H]carnitine uptake via OCTN2 is speci¢c to the
change of membrane potential. Considering this re-
sult, the e¡ect of inorganic anions shown in Fig. 3b
and the stoichiometry of L-carnitine and Na in Fig.
4b demonstrate that Na-dependent L-carnitine
transport via OCTN2 is electrogenic.
3.6. Immunohistochemical localization of
OCTN2 in kidney
OCTN2 is presumed to take up L-carnitine into
renal tubular epithelial cells across the apical mem-
brane in an Na-dependent manner. So, the local-
ization of OCTN2 in kidney was examined using
anti-mouse OCTN2 antibody. We prepared an anti-
peptide antibody to mice OCTN2. Since only two
amino acid residues within the peptide sequence
used for preparation of the antibody are di¡erent
between mouse and rat OCTN2, the mouse
OCTN2 antibody could be used for detection of
OCTN2 in rat kidney. As shown in Fig. 6, the anti-
body reacted at the apical membrane of the renal
epithelial cells (Fig. 6a,c), while no reaction was ob-
served when normal IgG was used as a control (Fig.
6b). No staining was detected in basolateral mem-
brane of the epithelial cells. So, OCTN2 was con-
cluded to be expressed at the apical membrane of
renal tubular epithelial cells.
4. Discussion
The present study was focused on the role of Na
in the OCTN2-mediated transport of L-carnitine.
Previous studies on L-carnitine transport demon-
strated that an Na-dependent transport system is
involved. However, some studies suggested that
Na-dependent binding of L-carnitine is predominant
and L-carnitine transport is not necessarily coupled
with the £ux of Na [4,5,9^11]. So, in the present
study we examined whether Na is transported
with L-carnitine or not by studying L-carnitine up-
take by membrane vesicles prepared from cells trans-
fected with human OCTN2.
First of all, we prepared HEK293 cells stably
transfected with human OCTN2 by screening the
L-carnitine transport activity and by RT-PCR specif-
ic to human OCTN2. Among several cell lines ob-
tained, we chose one line that exhibited high expres-
sion of L-carnitine transport activity. The cell line
was con¢rmed by RT-PCR to express the human
OCTN2 gene. From this cell line we prepared
membrane vesicles and further examined the trans-
port of L-carnitine. To distinguish the binding of
L-[3H]carnitine to the membrane vesicles from trans-
port, the osmolarity e¡ect on the uptake of
L-[3H]carnitine was examined. The membrane
vesicles were incubated with L-[3H]carnitine in the
presence of extravesicular Na for 1 min, for evalu-
ation of the initial uptake of L-carnitine, then treated
with standard isotonic or hypotonic stop solution to
examine the e¡ect of osmotic disruption. When
membrane vesicles were disrupted by hypotonic
stop solution, the uptake was signi¢cantly decreased
in the case of the membrane vesicles from the
OCTN2-transfected HEK293 cells, while there was
little e¡ect in the case of membrane vesicles from
mock cells, demonstrating that the apparent uptake
of L-[3H]carnitine in OCTN2-expressing vesicles was
largely due to the intravesicular uptake rather than
to the binding, although the partial contribution of
Na-dependent binding cannot be excluded as was
demonstrated in other tissues [9]. In fact, when we
evaluated the osmolarity e¡ect on the steady-state
uptake of L-carnitine to the membrane vesicles, it
was estimated that about 10% of the total uptake
was not sensitive to the extravesicular osmolarity
(data not shown). Next, the time courses of uptake
of L-[3H]carnitine were studied in the presence or
absence of extravesicular Na in OCTN2-expressing
and mock membrane vesicles. The initial uptake of L-
[3H]carnitine at 2 min by membrane vesicles from the
OCTN2-expressing cells was very high in the pres-
ence of Na and decreased by 15 min, showing a
clear overshoot uptake. Uptakes of L-[3H]carnitine
by OCTN2-expressing cells in the absence of Na
and by mock vesicles either in the presence or ab-
sence of Na did not show such an increase at the
initial state. Furthermore, the di¡erence in the up-
takes at the steady state between in the presence
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and the absence of Na was small in OCTN2-ex-
pressing membrane vesicles. This result strongly sug-
gests that Na is coupled with the transport of L-
[3H]carnitine in a secondary active transport mecha-
nism and that Na-dependent binding to OCTN2 is
negligible in total uptake. When extravesicular Na
was replaced with other cations, the initial uptake
was signi¢cantly decreased, though lithium ions sup-
ported an intermediate uptake activity. Other cations
such as potassium, rubidium, cesium, choline, or N-
methylglucamine did not support the speci¢c trans-
port of L-[3H]carnitine. It is often observed that lith-
ium ions partially support the Na-coupled trans-
port. So, human OCTN2-mediated transport of
L-carnitine has the characteristics of an Na-coupled
mechanism. Partial stimulation of L-carnitine uptake
by Li was also consistent with previous observa-
tions in Na-dependent transport of L-carnitine by
the renal and placental brush-border membrane
vesicles [9,11], while in the case of placenta, no over-
shoot uptake of L-carnitine was observed in the pres-
ence of Na gradient. Furthermore, hepatic basolat-
eral membrane transport of L-carnitine also showed
Na dependence and the activity was partially sup-
ported by Li. On the other hand, Li induced com-
parable uptake of L-carnitine with Na in rat muscle
vesicles [5], suggesting an involvement of a transport-
er in muscle other than OCTN2. These results sug-
gest that OCTN2 may be involved in the transport of
L-carnitine in several tissues such as kidney, placenta
and liver, but not in all tissues.
The initial uptake of L-carnitine was saturable with
a Km value of 2.66 þ 0.75 WM, which is consistent
with the value obtained using HEK293 cells transi-
ently transfected with human OCTN2, 4.3 WM [14].
Based on the Km value, the stoichiometry of L-carni-
tine and Na was examined by changing the extra-
vesicular Na concentration from 0 to 150 mM at
the L-[3H]carnitine concentration of 40 nM, which is
signi¢cantly lower than the Km value of L-carnitine
itself or the sodium concentration used to allow the
kinetic evaluation of the e¡ect of Na concentration.
The Hill coe⁄cient 0.88 was close to unity as the
same as observed in the study using HEK293 cells
transiently expressing human OCTN2, 0.926 [18],
whereas the apparent Km value of Na (Km;Na)
2.34 mM in the present study was rather small com-
pared with previously reported Km;Na 18.5 mM in
HEK293 cells [18]. The di¡erence in Km;Na may be
ascribed to the di¡erential experimental methods, but
the Hill coe⁄cient, which means the stoichiometry of
the cotransport of L-carnitine and Na, was close to
unity in both experiments. So, it is strongly suggested
that one L-carnitine molecule is transported with one
Na molecule via human OCTN2. Since L-carnitine
is zwitterionic with the pKa value of the carboxylic
acid moiety being 3.8 [31] and a positively charged
trimethylammonium moiety, it is assumed that the
transport of L-carnitine with Na is electrogenic.
When membrane potential was clamped by using va-
linomycin-induced potassium £ux, Na-dependent
uptake of L-[3H]carnitine was increased compared
with the uptake in the absence of valinomycin. In
addition, when the chloride ion in the extravesicular
medium was replaced with other inorganic anions
such as thiocyanate, nitrate, gluconate or sulfate
ions, some changes in L-[3H]carnitine uptake were
observed. Membrane-permeable nitrate signi¢cantly
increased the uptake, while membrane-impermeable
gluconate or sulfate decreased the uptake. Mem-
brane-permeable thiocyanate showed some increase
(not statistically signi¢cant). The e¡ect of inorganic
anions is not speci¢c and may occur via a change of
the membrane potential di¡erence due to the di¡er-
ence of membrane permeability among ionic species.
These observations suggest that membrane potential
a¡ects the transport of L-[3H]carnitine.
Overall, our results indicated that L-carnitine
transport via OCTN2 is electrogenic owing to cou-
pling with the £ux of Na. Recently, it was demon-
strated that L-carnitine transport is electrogenic in
electrophysiological studies using Xenopus oocytes
expressing human OCTN2 [32], although the £ux
of L-carnitine itself was not measured in that study.
In the present study, we directly measured the elec-
trogenic transport of L-carnitine itself and our ¢nd-
ing is consistent with the result obtained by the elec-
trophysiological approach. All of these results
demonstrate that transport of L-carnitine via
OCTN2 is coupled with Na and the e¡ect of Na
cannot be ascribed to binding to the transporter but
to transport via OCTN2.
Physiologically, OCTN2 plays a role in the reab-
sorption of glomerularly ¢ltered L-carnitine across
the renal tubular epithelial cells, as well as in tissue
distribution to liver and other tissues [33,34]. To
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maintain the physiological concentration of L-carni-
tine, reabsorption in kidney is very important. An
SCD animal model, jvs mouse, has mutated
OCTN2, consequently lacking L-carnitine transport
activity [20]. Plasma concentrations of free and total
carnitine in jvs mice are signi¢cantly lower than those
of wild mice and this is assumed to be caused by the
absence of reabsorption in kidney, because renal
clearance of L-carnitine is signi¢cantly increased in
jvs mice [33]. So, we con¢rmed the localization of
OCTN2 in kidney. In mice, OCTN2 is located on
the luminal side of renal tubular epithelial cells ac-
cording to immunohistochemical analysis. Similarly,
the rat OCTN2 was found to be localized on the
luminal side of the epithelial cells. In addition, our
preliminary result of £uorescence immunohistochem-
ical study suggested the limited expression of
OCTN2 in proximal tubule but not in distal tubule
of kidney. Therefore, we have demonstrated that
OCTN2 is localized at the apical membrane of renal
tubular epithelial cells and functions to reabsorb
L-carnitine in kidney. Recently, we demonstrated
that mouse OCTN2 exhibited a mutual trans-stimu-
lation of Na-dependent carnitine in£ux and an ef-
£ux of organic cation tetraethylammonium, suggest-
ing an e⁄cient transport for reabsorption of
physiological compounds and secretion of xenobiot-
ics in kidney [19]. However, in the absence of
Na, tetraethylammonium in the trans-side could
not drive the in£ux of L-carnitine in HEK293 cells
[19]. So, OCTN2 obligatory requires Na for the
active transport of L-carnitine and the organic cati-
ons in the trans-side may have only an additive
e¡ect on Na-dependent L-carnitine transport via
OCTN2.
In conclusion, it was demonstrated, using mem-
brane vesicles prepared from cells transfected with
OCTN2, that the Na dependence of OCTN2-medi-
ated transport of L-carnitine is due to coupled trans-
port leading to the electrogenic, secondary active
transport, but not to binding to the transporter. Fur-
thermore, OCTN2 was shown to be located on the
apical membrane of renal tubular epithelial cells.
Although the roles of OCTN2 in other tissues are
not yet known, it is already clear that OCTN2 is
important to maintain L-carnitine concentration in
the body by reabsorbing L-carnitine in a sodium-
coupled electrogenic transport manner.
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